Palatin Technologies, Inc. (PTN)
26.13
-1.37
(-4.98%)
USD |
NYAM |
Dec 10, 14:41
Palatin Technologies EPS Diluted (Quarterly): 4.258 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.678M |
| Revenue (Quarterly) | 8.848M |
| Total Expenses (Quarterly) | 4.17M |
| Enterprise Value | 24.42M |
| Profit Margin (Quarterly) | 52.87% |
| Earnings Yield | -16.23% |
| Normalized Earnings Yield | -16.23 |